A possible decline in the incidence and severity of Behçet's disease: Implications for an infectious etiology and oral health

Clinical and Experimental Rheumatology

Volumn 28, Issue 4 SUPPL. 60, 2010, Pages

  Direskeneli, Haner ^a   Mumcu, Gonca ^a  

^a MARMARA UNIVERSITY   (Turkey)

Author keywords

Beh et's disease; Decline; Infection; Oral health

Indexed keywords

ACNE; ARTHRITIS; AUTOIMMUNE DISEASE; BEHCET DISEASE; DENTAL CARIES; DISEASE ASSOCIATION; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; ESCHERICHIA COLI; ETHNIC DIFFERENCE; GEOGRAPHIC DISTRIBUTION; HUMAN; IMMUNE RESPONSE; INCIDENCE; INFECTION; INFLAMMATORY DISEASE; JAPANESE; MOUTH INFECTION; PREVALENCE; PREVOTELLA; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; REVIEW; SAPHO SYNDROME; STAPHYLOCOCCUS AUREUS;

BEHCET SYNDROME; EUROPE; HUMANS; INCIDENCE; JAPAN; MOUTH DISEASES; ORAL HEALTH; SEVERITY OF ILLNESS INDEX; TURKEY;

EID: 78049404541     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. SAKANE T, TAKENO M, SUZUKI N, INABA G: Behçet's disease. N Engl J Med 1999; 341: 1284-91.
2. ERTAM I, KITAPCIOGLU G, AKSU K et al.: Quality of life and its relation with disease severity in Behçet's disease. Clin Exp Rheumatol 2009; 27(Suppl. 53): S18-22.
3. KURAL-SEYAHI E, FRESKO I, SEYAHI N et al.: The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 2003; 82: 60-76.
4. DIRESKENELI H: Behçet's Disease: Infectious etiology, new auto-antigens and HLA-B51. Ann Rheum Dis 2001; 60: 996-1002.
5. YAZICI H, SEYAHI E, YURDAKUL S: Behçet's syndrome is not so rare: why do we need to know? Arthritis Rheum 2008; 58: 3640-3.
6. MAHR A, BELARBI L, WECHSLER B et al.: Population-based prevalence study of Behçet's disease: Differences by ethnic origin and low variation by age at immigration. Arthritis Rheum 2008; 58: 3951-9.
7. CAKIR N, DERVIS E, BENIAN O et al.: Prevalence of Behçet's disease in rural western Turkey: a preliminary report. Clin Exp Rheumatol 2004; 22 (Suppl. 34): S53-5.
8. YURDAKUL S, GÜNAYDIN I, TÜZÜN Y et al.: The prevalence of Behçet's syndrome in a rural area in northern Turkey. J Rheumatol 1988; 15: 820-2.
9. AZIZLERLI G, KÖSE AA, SARICA R et al.: Prevalence of Behçet's disease in Istanbul, Turkey. Int J Dermatol 2003; 42: 803-6.
10. IDIL A, GÜRLER A, BOYVAT A et al.: The prevalence of Behçet's disease above the age of 10 years. The results of a pilot study conducted at the Park Primary Health Care Center in Ankara, Turkey. Ophthalmic Epidemiol 2002; 9: 325-31.
11. SEYAHI E, MANGAN MS, OKTAY V, CEVIRGEN D, MURATYAN S, YAZICI H: The prevalence of familial Mediterranean fever and Behçet's syndrome among Armenians living in Istanbul: preliminary results of a survey. Ann Rheum Dis 2007; 66 (Suppl. II): ii252.
12. PAPOUTSIS NG, ABDEL-NASER MB, ALTENBURGA et al.: Prevalence of Adamantiades-Behçet's disease in Germany and the municipality of Berlin: results of a nationwide survey. Clin Exp Rheumatol 2006; 24 (Suppl. 42): S125.
13. OZEN S, AKTAY N, LAINKA E, DUZOVA A, BAKKALOGLU A, KALLINICH T: Disease severity in children and adolescents with familial Mediterranean fever: a comparative study to explore environmental effects on a monogenic disease. Ann Rheum Dis 2009; 68: 246-8.
14. HIROHATA T, KURATSUNE M, NOMURA A, JIMI S: Prevalence of Behçet's syndrome in Hawaii. With particular reference to the comparison of the Japanese in Hawaii and Japan. Hawaii Med J 1975; 34: 244-6.
15. WAKABAYASHI T, MORIMURA Y, MIYAMOTO Y, OKADA AA: Changing patterns of intraocular inflammatory disease in Japan. Ocul Immunol Inflamm 2003; 11: 277-86.
16. GOTO H, MOCHIZUKI M, YAMAKI K, KOTAKE S, USUI M, OHNO S: Epidemiological survey of intraocular inflammation in Japan. Jpn J Ophthalmol 2007; 51: 41-4.
17. YOSHIDA A, KAWASHIMA H, MOTOYAMA et al.: Comparison of patients with Behçet's disease in the 1980s and 1990s. Ophthalmology 2004; 111: 810-5.
18. KITAMEI H, KITAICHI N, NAMBA K et al.: Clinical features of intraocular inflammation in Hokkaido, Japan. Acta Ophthalmol 2009; 87: 424-8.
19. KEINO H, NAKASHIMA C, WATANABE T et al.: Frequency and clinical features of intraocular inflammation in Tokyo. Clin Experiment Ophthalmol. 2009; 37: 595-601.
20. KAZOKOGLU H, ONAL S, TUGAL-TUTKUN I et al.: Demographic and clinical features of uveitis in tertiary centers in Turkey. Ophthalmic Epidemiol 2008; 15: 285-93.
21. CHUNG Y-M, LIN Y-C, TSAI C-C, HUANG D-F: Behçet's Disease with Uveitis in Taiwan. J Chin Med Assoc 2008; 71: 509-16.
22. TUGAL-TUTKUN I, ONAL S, ALTAN-YAYCIOGLU R, ALTUNBAS H, URGANCIOGLU M: Uveitis in Behçet disease: an analysis of 880 patients. Am J Ophthalmol 2004; 138: 373-80.
23. KUMP LI, MOELLER KL, REED GF, KURUP SK, NUSSENBLATT RB, LEVY-CLARKE GA: Behçet's disease: comparing 3 decades of treatment response at the National Eye Institute. Can J Ophthalmol 2008; 43: 468-72.
24. SEYAHI E, UGURLU S, SEYAHI N et al.: A survey of socioeconomic status Behçet's Syndrome. XI International Conference on Behçet's disease. Clin Exp Rheumatol 2004; 22 (Suppl. 34): 4: A27.
25. BACH JF: Infections and auto-immune diseases: Review. J Autoimmunity 2005; 25: 74-80.
26. BACH JF: The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002; 347: 911-20.
27. ROMAGNANI S: The increased prevalence of allergy and the hygine hypothesis: missing immune deviation, reduced immune suppression or both ? Immunology 2004; 112: 352-63.
28. CHANG HK, LEE SS, KIM JW et al.: The prevalence of atopy and atopic diseases in Behçet's disease. Clin Exp Rheumatol 2003; 21 (Suppl. 30): S31-4.
29. TEMEL M, ATAGUNDUZ P, TAŞAN D et al.: Atopy in Behcet's disease is associated with disease severity. XI. International Congress on Behçet's Disease. Clin Exp Rheumatol 2004; 22 (Suppl. 34): 4: D28.
30. DINÇ A, KARAAYVAZ M, CALISKANER AZ, PAY S, ERDEM H, TURAN M: Dermographism and atopy in patients with Behçet's disease. J Investig Allergol Clin Immunol 2000; 10: 368-71.
31. PATTERSON CC, CARSON DJ, HADDEN DR: Epidemiology of childhood IDDM in Northern Ireland 1989-1994: low incidence in areas with highest population density and most household crowding. Northern Ireland Diabetes Study Group. Diabetologia 1996; 39: 1063-9.
32. DIRESKENELI H: Autoimmunity vs autoinflammation in Behçet's disease: do we oversimplify a complex disorder? Rheumatology 2006; 45: 1461-5.
33. BARTŮNKOVÁ J, KAYSEROVÁ J, SHOENFELD Y: Allergy and autoimmunity: parallels and dissimilarity: the yin and yang of immunopathology. Autoimmun Rev 2009; 8: 302-8.
34. MUMCU G, INANC N, YAVUZ S, DIRESKENELI H: The role of infectious agents in the Pathogenesis, Clinical Manifestations and Treatment Strategies in Behçet's Disease-Review. Clin Exp Rheumatol 2007; 25 (Suppl. 45): S27-33.
35. HATEMI G, BAHAR H, UYSAL S et al.: The pustular skin lesions in Behçet's syndrome are not sterile. Ann Rheum Dis 2004; 63: 1450-2.
36. DIRI E, MAT C, HAMURYUDAN V, YURDAKUL S, HIZLI N, YAZICI H: Papulopustular skin lesions are seen more frequently in patients with Behçet's syndrome who have arthritis: a controlled and masked study. Ann Rheum Dis 2001; 60: 1074-6.
37. GOVONI M, COLINA M, MASSARA A, TROTTA F: "SAPHO syndrome and infections". Autoimmun Rev 2009; 8: 256-9.
38. CALGUNERI M, KIRAZ S, ERTENLI I, BENEKLI M, KARAARSLAN Y, CELIK I: The effect of Prophylactic penicillin treatment on the course of arthritis episodes in patients with Behçet's disease. A randomized clinical trial. Arthritis Rheum 1996; 39: 2062-5.
39. PETERSEN PE, YAMAMOTO T: Improving the oral health of older people: the approach of The WHO global oral health programme. Community Dent Oral Epidemiol 2005; 33: 81-92. (Pubitemid 41577044)
40. KANEKO F, OYAMA N, YANAGIHORI H, ISOGAI E, YOKOTA K, OGUMA K: The role of streptococcal hypersensitivity in the pathogenesis of Behçet's disease. Eur J Dermatol 2008; 18: 489-98.
41. YOSHIKAWA K, KOTAKE S, SASAMOTO Y, OHNO S, MATSUDA H: Close association of Streptococcus sanguis and Behçet's Disease. Nippon Ganka Gakkai Zasshi 1991; 95: 1261-7.
42. MIZUSHIMA Y: Behçet's Disease Research Committe of Japan, Skin hypersensitivity of streptococal antigens and the induction of systemic symptoms by the antigens in Behçet disease, J Rheumatol 1989; 16: 506-11.
43. ISOGAI E, ISOGAI H, KOTAKE S, OHNO S, KIMURA K, OGUMA K: Role of Streptococcus sanguis and traumatic factors in Behçet's disease. J Appl Res 2003; 3: 64-75.
44. CHOI SM, CHOI YJ, KIM JT et al.: A Case of Recurrent Neuro- Behçet's Disease after Tooth Extraction. J Korean Med Sci 2010; 25: 185-7.
45. KANEKO F, OYAMA N, NISHIBU A: Streptococcal infection in the pathogenesis of Behçet's Disease and clinical effects of minocycline on the disease symptoms. Yonsei Med J 1997; 38; 444-54.
46. MUMCU G, ERGUN T, ELBIR Y et al.: Clinical and immunological effects of azithromycin in Behçet's disease. J Oral Pathol Med 2005; 34: 13-6.
47. CALGUNERI M, ERTENLI I, KIRAZ S, ERMAN M, CELIK I: Effect of prophylactic benzathine penicilline on mucocutaneous symptoms of Behçet's Disease. Dermatology 1996; 192: 125-8.
48. MUMCU G, ERGUN T, INANC N et al.: Oral health is impaired in Behçet's disease and associate with disease severity. Rheumatology 2004; 43: 1028-33.
49. HAYRAN O, MUMCU G, INANC N, ERGUN T, DIRESKENELI H: Assessment of minimal clinically important improvement by using Oral Health Impact Profile-14 in Behçet's disease. Clin Exp Rheumatol 2009; 27 (Suppl. 53): S79-84.
50. MUMCU G: Behçet's disease: a dentist's overview. Clin Exp Rheumatol 2008; 26 (Suppl. 50): S121-4.
51. ISOGAI E, ISOGAI H, KOTAKE S et al.: Antibody cross-reactivity from sera of patients with Behçet's disease with synthetic peptides that have homologies with proteins from Streptococcus sanguis. J Appl Res 2002; 2: 185-191
52. MIURA T, ISHIHARA K, KATO T et al.: Detection of heat shock proteins but not superantigen by isolated oral bacteria from patients with Behçet's disease. Oral Microbiol Immunol 2005; 20: 167-71.
53. YAVUZ S, ELBIR Y, TULUNAY A, EKSIOGLUDEMIRALP E, DIRESKENELI H: Differential expression of toll-like receptor 6 on granulocytes and monocytes implicates the role of microorganisms in Behçet's disease etiopathogenesis. Rheumatol Int 2008; 28: 401-6.
54. CUCHACOVICH M, MERINO G, YAMAMOTO JH et al.: Behçet's disease patients present high levels of deglycosylated anti-lipoteikoic acid IgG and high IL-8 production after lipoteikoic acid stimulation. Clin Exp Rheumatol 2005; 23 (Suppl. 38): S27-S34.
55. DIRESKENELI H, DIRESKENELI G: The role of heat shock proteins in Behçet's disease. Clin Exp Rheumatol 2003; 21 (Suppl. 30): S44-8.
56. WHO oral health country area profiles programme. http://www.whocollab.od. mah.se/wpro/japan/data/japancar.html (24.01.2009).
57. WHO oral health country area profiles programme. http://www.whocollab.od. mah.se/euro/turkey/data/turkeycar.html (24.01.2009).
58. SAKURAI H: Healthy Japan 21. JMAJ 2003; 46: 47-9.
59. FRIEDRICH N, VÖLZKE H, SCHWAHN C et al.: Inverse association between periodontitis and respiratory allergies. Clin Exp Allergy 2006; 36: 495-502.
60. WHO periodontal profile. http://www.dent.niigata-u.ac.jp/prevent/perio/ perio.html. (24.01.2009).
61. KARACAYLI U, MUMCU G, SIMSEK I et al.: The close association between dental and periodontal treatments and oral ulcer course in Behçet's Disease: A prospective clinical study. J Oral Pathol Med 2009; 38: 410-5.
62. INOUE CN, NAGASAKA T, MATSUTANI S, ISHIDOYA M, HOMMA R, CHIBA Y: Efficacy of early dental and ENT therapy in preventing nephropathy in pediatric Henoch-Schönlein purpura. Clin Rheumatol 2008; 27: 1489-96.
63. SCHULZE C, MUNOZ LE, FRANZ S et al.: Clearance deficiency - a potential link between infections and autoimmunity. Autoimmun Rev 2008; 8: 5-8.
64. INANC N, MUMCU G, BIRTAS E et al.: Serum mannose-binding lectin levels are decreased in Behçet's disease and associated with disease severity. J Rheumatol 2005; 32: 287-91.
65. MUMCU G, INANC N, AYDIN SZ, ERGUN T, DIRESKENELI H: Association of Salivary S. mutans colonization and mannose-binding lectin deficiency with gender in Behçet's disease. Clin Exp Rheumatol 2009; 27 (Suppl. 53): S32-S36.